We have the ability to provide services such as early research, process development and production, formulation development and formulation production, analytical method development and validation, and global new drug registration support for protein-drug conjugates such as ADCs, AOCs, and RDCs. We are committed to providing integrated CDMO services for all stages of protein and drug conjugate development and launch to global pharmaceutical companies in accordance with international standards.
Learn how Porton Biologics and Conjugates CDMO Service provide your premier solutions.
